Evaluating a Combined Exercise, Anti-inflammatory, and Dietary Intervention for Kidney Cachexia in Patients on Haemodialysis A Feasibility Randomized Controlled Trial
Led by Queen's University, Belfast · Updated on 2026-08-26
40
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying kidney cachexia, a condition causing severe muscle loss, weakness, fatigue, poor appetite, and reduced quality of life in patients with kidney failure who are undergoing haemodialysis. This study evaluates whether a combined treatment approach, including exercise, dietary advice, and anti-inflammatory supplements, can improve outcomes compared to routine kidney care alone. The study focuses on patients at risk of kidney cachexia, aiming to assess the practicality and potential benefits of this integrated intervention in the healthcare system.
Participants in the treatment group will receive a personalized exercise program involving aerobic and resistance training, dietary advice through one-on-one dietetic assessments and food diaries, and daily omega-3 oral supplements for 12 weeks. Weekly phone contacts will support adherence. The control group will continue with routine care without these additional interventions. The study uses a randomized, parallel design across multiple renal departments.
During the 12-week study, participants will be monitored for recruitment success, physical function, muscle mass, body weight, quality of life, and survival. Data collection includes exercise diaries, dietary records, and interviews with patients and clinicians after treatment to identify improvements to the intervention. Researchers will evaluate how well the combined treatment works and its feasibility, with a focus on patient engagement and clinical outcomes related to kidney cachexia.
CONDITIONS
Brief Title
A Multimodal Integrated Intervention for Kidney Cachexia
Research Team
J
Joanne Reid, PhD
C
Carolyn Blair, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients with stage 5 chronic kidney disease receiving maintenance haemodialysis for more than 3 months
Unintentional weight loss of at least 5% in 12 months or body mass index less than 20 kg/m2
Self-reported decreased physical function, muscle strength, appetite, or increased fatigue
Able to provide written informed consent
You will not qualify if you...
Under 18 years of age
Patients within 3 months of starting haemodialysis
Weight loss due to known causes like malabsorption or oesophageal blockage
Receiving chronic anticoagulation therapy or with recent bleeding issues
Receiving immunosuppressants or immunomodulators
Pregnant or breastfeeding
Allergic to components of omega-3 supplements
Dementia, untreated psychiatric disorders, or severe cognitive impairment
Expected survival on dialysis less than 6 months
Considering dialysis withdrawal
Likely to receive live-donor transplant or switch to peritoneal dialysis during the study
Bilateral lower limb amputations
Clinically unstable as judged by doctor
Non-English speaking and unable to consent
Currently enrolled in other studies involving exercise or omega-3 or have taken omega-3 in past 3 months
Unable or unwilling to participate
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - 12 weeks
Participants in the treatment group receive a 12-week program including individualized exercise, dietary advice, and daily omega-3 supplements while continuing routine care. Control group participants continue routine care without these interventions.
Weekly telephone contact and periodic dietician reviews
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Study of Nanocrystalline Megestrol Acetate with Chemoradiotherapy in Advanced Cervical Cancer
Phase 1B Study of AV-380 Combined with Standard Chemotherapy in Adults with Metastatic Cancer and Cachexia with High GDF-15 Levels
Study Testing HTD1801 Capsules to Slow Kidney Damage in Adults With Type 2 Diabetes and Chronic Kidney Disease
Evaluating a Combined Exercise, Anti-inflammatory, and Dietary Intervention for Kidney Cachexia in Patients on Haemodialysis A Feasibility Randomized Controlled Trial
Phase I Study to Assess Safety and Early Effects of SXRN Plasmid DNA Treatment in Adults With Advanced Solid Tumors
Evaluating the Safety and Effectiveness of Veverimer Compared to Placebo in Adults with Chronic Kidney Disease and Metabolic Acidosis
Evaluating Ponsegromab with Chemotherapy for Adults with Metastatic Pancreatic Cancer and Cachexia in a Randomized Double-Blind Study
Study of AdiaVita Stem Cell and Glutathione Treatment for Adults with Chronic Kidney Disease
Study of Gene Variations Linked to Cancer Cachexia in Adults with Advanced Pancreatic Adenocarcinoma
Study of Body Composition, Psychosocial Factors, and Medication Issues in Adults with Cancer Receiving Immune Checkpoint Inhibitors
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Multi-modal integrated intervention combining exercise, anti-inflammatory, and dietary advice (MMIEAD) for adults with kidney cachexia: protocol for a mixed-methods feasibility cluster randomised controlled trial and process evaluation.